Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Stroke Research and Treatment is Scopus-indexed (Q3, CiteScore 2.9), WoS ESCI, DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 2042-0056Verify ISSN ↗2090-8105Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 239 / 403 | 40th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q3, CiteScore 2.9.
Stroke Research and Treatment is Q3 in Neurology (clinical) (rank 239 of 403), by CiteScore 2025.
Stroke Research and Treatment is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.9, which places it in quartile Q3 at the 40th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.390, quartile Q3, with an H-index of 49.
The publisher lists an article processing charge of about US$1,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Stroke Research and Treatment is published by John Wiley and Sons Ltd. Its print ISSN is 2042-0056 and its online ISSN is 2090-8105.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Stroke Research and Treatment has an h-index of 58 and a 2-year mean of 1.45 citations per paper (OpenAlex). Its Scopus CiteScore is 2.9, quartile Q3. On 2-year citations it ranks #210 of 403 Scopus journals in Neurology (clinical).
Stroke Research and Treatment published 16 papers in 2025; its busiest recent year was 2021 with 21. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 77 research articles (2021–2026), authors are most often from United States (10.4%), Iran (9.1%) and Indonesia (7.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.